美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

施貴寶

63.64

-0.1100-0.17%

盤後：63.660.0195+0.03%19:55 EDT

成交量：705.58萬

成交額：4.48億

市值：1,295.55億

市盈率：14.01

高：64.20

開：64.15

低：63.27

收：63.75

52周最高：68.64

52周最低：42.52

股本：20.36億

流通股本：20.32億

量比：1.05

換手率：0.35%

股息：2.51

股息率：3.95%

每股收益(TTM):4.54

每股收益(LYR):3.46

淨資產收益率：46.60%

總資產收益率：10.72%

市淨率：5.80

市盈率(LYR):18.39

資料載入中...

總覽公司新聞公告

Replimune股價下跌，FDA受理皮膚癌藥審評，但諮詢委增添風險

數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易

施貴寶加拿大公司更新指南：治療後推薦在治療中心附近停留時間從28天縮短至14天

施貴寶旗下Breyanzi CAR-T細胞療法在加拿大獲批監測與活動更新

中國哈伯生物醫藥在獲賠2000萬美元后將聚焦另一項專利訴訟

武田製藥的AI研發銀屑病口服藥在頭對頭試驗中勝過百時美施貴寶的Sotyktu

百時美施貴寶(BMY)股票6月8日收盤下跌3.00%：真相來了

TradingKey中文

異動解讀｜施貴寶盤中上漲3.13%，多重利好疊加行業回暖共振

健康快訊：放射性植入物可改善腦癌手術後的治療效果

百時美施貴寶：Iza-Bren在重度經治患者群體中展現可控安全性，未觀察到新的安全信號

施貴寶Izalontamab Brengitecan在TNBC和ESCC中展現顯著的OS與PFS改善

異動解讀｜施貴寶盤中下跌3.1%，報55.2美元

FDA優先審評施貴寶Camzyos補充新藥申請，用於治療青少年症狀性梗阻性肥厚型心肌病

施貴寶免疫療法組合獲批用於治療既往未治療的III/IV期經典霍奇金淋巴瘤成人與青少年患者（12歲及以上）

施貴寶宣佈歐狄沃®聯合AVD療法獲歐盟擴大標籤，獲批用於一線治療晚期經典型霍奇金淋巴瘤

Incyte的血液癌症聯合用藥方案可降低疾病進展風險，但副作用發生率較高

Replimune的皮膚癌藥物在美國獲批迎來第三次機會

百時美施貴寶的藥物可延緩難治性多發性骨髓瘤患者的病情進展

施貴寶：Mezikd顯著提升二/三線及高危疾病患者無進展生存期

施貴寶：Mezikd安全性特徵與已知的Mezigdomide及聯合療法特徵一致

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BMY/news?page=7"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"施貴寶","latestPrice":63.64,"timestamp":1789156800000,"preClose":63.75,"halted":0,"volume":7055795,"hourTrading":{"tag":"盘后","latestPrice":63.6595,"preClose":63.64,"latestTime":"19:55 EDT","volume":456182,"amount":29031235.1174,"timestamp":1789170948935,"change":0.0195,"changeRate":0.000306,"amplitude":0.004714},"delay":0,"changeRate":-0.0017254901960784225,"floatShares":2031646263,"shares":2035753027,"eps":4.542906,"marketStatus":"休市中","change":-0.11,"latestTime":"09-11 16:00:00 EDT","open":64.15,"high":64.2,"low":63.27,"amount":448248320.24609,"amplitude":0.014588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.542906,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":63.75,"dividendRate":0.039472,"preHourTrading":{"tag":"盘前","latestPrice":64.34,"preClose":63.75,"latestTime":"09:20 EDT","volume":2961,"amount":193079.76282,"timestamp":1789132811753,"change":0.59,"changeRate":0.009255,"amplitude":0.016784},"postHourTrading":{"tag":"盘后","latestPrice":63.6595,"preClose":63.64,"latestTime":"19:55 EDT","volume":456182,"amount":29031235.1174,"timestamp":1789170948935,"change":0.0195,"changeRate":0.000306,"amplitude":0.004714},"volumeRatio":1.0485886650682261,"impliedVol":0.2522,"impliedVolPercentile":0.0717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2031646263,"roa":"10.72%","roe":"46.60%","lyrEps":3.46,"volumeRatio":1.0485886650682261,"shares":2035753027,"dividePrice":2.512,"high":64.2,"amplitude":0.014588,"preClose":63.75,"low":63.27,"week52Low":42.52,"pbRate":"5.80","psRate":"2.63","week52High":68.64,"institutionHeld":0.7397,"latestPrice":63.64,"eps":4.542906,"divideRate":0.039472,"volume":7055795,"delay":0,"ttmEps":4.542906,"open":64.15,"prevYearClose":53.94,"prevWeekClose":66.82,"prevMonthClose":66.81,"prevQuarterClose":57.62,"fiveDayClose":68.09,"twentyDayClose":64.65,"sixtyDayClose":55.92,"dividendPayoutRate":0.7151007066521378,"dividendFrequency":"Q","dividendGrowthYears":4,"dividendGrowthRate":0.03333333333333337,"fiveYearAvgDividendRate":0.037305679384724975},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"date":"2026-10-29","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/09","expectedEps":1.68,"defaultRemindTime":1793260800000,"name":null,"time":"盤前","dateTimestamp":1793246400000,"actualEps":null},{"date":"2026-07-30","symbol":"BMY","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":1.59,"defaultRemindTime":1785398400000,"name":null,"time":"盤前","dateTimestamp":1785384000000,"actualEps":null},{"date":"2026-07-02","symbol":"BMY","amount":0.63,"announcedDate":"2026-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-07-02","defaultRemindTime":1782999000000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-03","payableDate":"2026-07-02","currency":"USD","dateTimestamp":1782964800000,"payDate":"2026-08-03"},{"market":"US","date":"2026-04-30","symbol":"BMY","fiscalQuarterEnding":"2026/03","expectedEps":1.44,"name":null,"time":"盤前","type":"earning","dateTimestamp":1777521600000,"reportTimeType":"pre","actualEps":1.58},{"date":"2026-04-02","symbol":"BMY","amount":0.63,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-02","defaultRemindTime":1775136600000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-05-01","payableDate":"2026-04-02","currency":"USD","dateTimestamp":1775102400000,"payDate":"2026-05-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-05","recordDate":"2016-10-07","paymentDate":"2016-11-01","value":0.38,"currency":"USD"},{"executeDate":"2017-04-05","recordDate":"2017-04-07","paymentDate":"2017-05-01","value":0.39,"currency":"USD"},{"executeDate":"2017-07-05","recordDate":"2017-07-07","paymentDate":"2017-08-01","value":0.39,"currency":"USD"},{"executeDate":"2017-10-05","recordDate":"2017-10-06","paymentDate":"2017-11-01","value":0.39,"currency":"USD"},{"executeDate":"2018-01-04","recordDate":"2018-01-05","paymentDate":"2018-02-01","value":0.4,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.2,"hold":0.5667,"sell":0.0333,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2,"analysts":30,"updateTime":1785988800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2026-09-11","current":14.008654,"percent":0.37215,"low":-27.493132,"twenty":-14.410285,"median":16.544918,"eighty":22.406055,"high":27.240851,"avg":8.902626,"sd":16.943774,"marketCap":130223059320},"quantilePoints":[{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-25","current":18.285308,"twenty":-24.204041,"median":12.026806,"eighty":23.356243,"marketCap":99088084638},{"date":"2025-05-02","current":18.63081,"twenty":-24.204041,"median":12.026806,"eighty":23.317376,"marketCap":100960358984},{"date":"2025-05-09","current":17.605571,"twenty":-24.204041,"median":12.026806,"eighty":23.272318,"marketCap":95404588372},{"date":"2025-05-16","current":17.203737,"twenty":-24.204041,"median":12.026806,"eighty":23.222393,"marketCap":93227051906},{"date":"2025-05-23","current":17.661903,"twenty":-24.204041,"median":12.026806,"eighty":23.160274,"marketCap":95709850494},{"date":"2025-05-30","current":17.96985,"twenty":-24.204041,"median":12.026806,"eighty":23.102683,"marketCap":97378616758},{"date":"2025-06-06","current":17.966094,"twenty":-24.204041,"median":12.026806,"eighty":23.03988,"marketCap":97358265950},{"date":"2025-06-13","current":19.036399,"twenty":-24.204041,"median":12.026806,"eighty":23.001392,"marketCap":103158246258},{"date":"2025-06-20","current":17.590549,"twenty":-24.206195,"median":12.014526,"eighty":22.956332,"marketCap":95323185140},{"date":"2025-06-27","current":17.519195,"twenty":-24.206195,"median":12.014526,"eighty":22.892874,"marketCap":94936519786},{"date":"2025-07-03","current":17.620593,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"marketCap":95485991605},{"date":"2025-07-11","current":18.221465,"twenty":-24.206195,"median":12.014526,"eighty":22.701406,"marketCap":98742120901},{"date":"2025-07-18","current":18.048714,"twenty":-24.206195,"median":12.014526,"eighty":22.649775,"marketCap":97805983728},{"date":"2025-07-25","current":18.379194,"twenty":-24.206195,"median":12.014526,"eighty":22.556783,"marketCap":99596854841},{"date":"2025-08-01","current":17.456793,"twenty":-24.206195,"median":12.014526,"eighty":22.431005,"marketCap":88139349881},{"date":"2025-08-08","current":18.286268,"twenty":-24.177472,"median":12.08226,"eighty":22.400619,"marketCap":92327369611},{"date":"2025-08-15","current":19.273953,"twenty":-24.112846,"median":12.183987,"eighty":22.400619,"marketCap":97314187414},{"date":"2025-08-22","current":19.523897,"twenty":-24.0554,"median":12.220826,"eighty":22.400619,"marketCap":98576157634},{"date":"2025-08-29","current":18.899036,"twenty":-23.982843,"median":12.274273,"eighty":22.400619,"marketCap":95421232085},{"date":"2025-09-05","current":18.82244,"twenty":-23.946253,"median":12.303101,"eighty":22.403337,"marketCap":95034499276},{"date":"2025-09-12","current":19.165106,"twenty":-23.839978,"median":12.319064,"eighty":22.400619,"marketCap":96764619738},{"date":"2025-09-19","current":18.383021,"twenty":-23.674822,"median":12.338712,"eighty":22.400619,"marketCap":92815874212},{"date":"2025-09-26","current":17.500152,"twenty":-23.592711,"median":12.357546,"eighty":22.400619,"marketCap":88358269727},{"date":"2025-10-03","current":18.435429,"twenty":-23.480943,"median":12.407479,"eighty":22.400619,"marketCap":93080480871},{"date":"2025-10-10","current":18.012136,"twenty":-23.373232,"median":12.486069,"eighty":22.400619,"marketCap":90943273241},{"date":"2025-10-17","current":17.49209,"twenty":-23.294244,"median":12.530276,"eighty":22.400619,"marketCap":88317561010},{"date":"2025-10-24","current":17.66947,"twenty":-23.222437,"median":12.579395,"eighty":22.400619,"marketCap":89213152779},{"date":"2025-10-31","current":15.376152,"twenty":-23.143449,"median":12.608867,"eighty":22.400619,"marketCap":92856582929},{"date":"2025-11-07","current":15.71902,"twenty":-22.870582,"median":12.65553,"eighty":22.400619,"marketCap":94927163649},{"date":"2025-11-14","current":16.393222,"twenty":-22.438742,"median":12.730369,"eighty":22.400619,"marketCap":98998669703},{"date":"2025-11-21","current":15.486421,"twenty":-16.752438,"median":12.823604,"eighty":22.400619,"marketCap":93522494060},{"date":"2025-11-28","current":16.58537,"twenty":-16.685372,"median":12.831164,"eighty":22.400619,"marketCap":100159048928},{"date":"2025-12-05","current":17.512398,"twenty":-16.548446,"median":12.905591,"eighty":22.400619,"marketCap":105757369752},{"date":"2025-12-12","current":17.259572,"twenty":-16.520502,"median":12.972348,"eighty":22.400619,"marketCap":104230554982},{"date":"2025-12-19","current":17.977597,"twenty":-16.472997,"median":13.017634,"eighty":22.400619,"marketCap":108566708929},{"date":"2025-12-26","current":18.442797,"twenty":-16.434176,"median":13.073071,"eighty":22.400619,"marketCap":111376048107},{"date":"2026-01-02","current":18.183229,"twenty":-16.414315,"median":13.188985,"eighty":22.400619,"marketCap":109808518276},{"date":"2026-01-09","current":18.843947,"twenty":-16.374704,"median":13.382921,"eighty":22.400619,"marketCap":113798594209},{"date":"2026-01-16","current":19.086659,"twenty":-16.353061,"median":13.69609,"eighty":22.400619,"marketCap":115264336388},{"date":"2026-01-23","current":18.52033,"twenty":-16.325165,"median":14.759881,"eighty":22.400619,"marketCap":111844271303},{"date":"2026-01-30","current":18.297843,"twenty":-16.272473,"median":14.817598,"eighty":22.400619,"marketCap":110500674305},{"date":"2026-02-06","current":17.177207,"twenty":-16.266274,"median":14.914668,"eighty":22.400619,"marketCap":121168020167},{"date":"2026-02-13","current":17.27533,"twenty":-16.266274,"median":15.187513,"eighty":22.400619,"marketCap":121860176196},{"date":"2026-02-20","current":17.408472,"twenty":-16.266274,"median":15.368435,"eighty":22.400619,"marketCap":122799364411},{"date":"2026-02-27","current":17.639431,"twenty":-16.266274,"median":15.435855,"eighty":22.400619,"marketCap":124428543375},{"date":"2026-03-06","current":17.535499,"twenty":-16.266274,"median":15.513389,"eighty":22.400619,"marketCap":123695412841},{"date":"2026-03-13","current":17.01873,"twenty":-16.266274,"median":15.649251,"eighty":22.400619,"marketCap":120050124909},{"date":"2026-03-20","current":16.776224,"twenty":-16.266274,"median":15.733204,"eighty":22.400619,"marketCap":118339486997},{"date":"2026-03-27","current":17.201636,"twenty":-16.266274,"median":15.863974,"eighty":22.400619,"marketCap":121340338090},{"date":"2026-04-02","current":17.867356,"twenty":-16.266274,"median":15.908979,"eighty":22.400619,"marketCap":126036329637},{"date":"2026-04-10","current":17.213213,"twenty":-16.266274,"median":15.985061,"eighty":22.400619,"marketCap":121422007508},{"date":"2026-04-17","current":17.065597,"twenty":-16.266274,"median":16.099944,"eighty":22.400619,"marketCap":120380722426},{"date":"2026-04-24","current":17.082964,"twenty":-16.179488,"median":16.17133,"eighty":22.400619,"marketCap":120503226554},{"date":"2026-05-01","current":17.004639,"twenty":-16.118108,"median":16.242165,"eighty":22.400619,"marketCap":123708751218},{"date":"2026-05-08","current":15.789211,"twenty":-16.03691,"median":16.265124,"eighty":22.400619,"marketCap":114866507643},{"date":"2026-05-15","current":15.935173,"twenty":-15.883379,"median":16.265124,"eighty":22.400619,"marketCap":115928384692},{"date":"2026-05-22","current":16.715511,"twenty":-15.830285,"median":16.286765,"eighty":22.400619,"marketCap":121605342758},{"date":"2026-05-29","current":15.974471,"twenty":-15.759799,"median":16.310377,"eighty":22.403337,"marketCap":116214274666},{"date":"2026-06-05","current":15.887455,"twenty":-15.710126,"median":16.30513,"eighty":22.400619,"marketCap":115581232580},{"date":"2026-06-12","current":15.971664,"twenty":-15.612322,"median":16.30513,"eighty":22.400619,"marketCap":116193853954},{"date":"2026-06-18","current":15.516935,"twenty":-15.534788,"median":16.30513,"eighty":22.400619,"marketCap":112885698534},{"date":"2026-06-26","current":15.547811,"twenty":-15.482096,"median":16.310377,"eighty":22.403337,"marketCap":113110326371},{"date":"2026-07-02","current":15.842543,"twenty":-15.420725,"median":16.328904,"eighty":22.403337,"marketCap":115254501180},{"date":"2026-07-10","current":16.263589,"twenty":-15.290382,"median":16.329552,"eighty":22.403337,"marketCap":118317608051},{"date":"2026-07-17","current":16.98498,"twenty":-15.209338,"median":16.380335,"eighty":22.403337,"marketCap":123565731155},{"date":"2026-07-24","current":17.265677,"twenty":-15.13895,"median":16.469151,"eighty":22.403337,"marketCap":125607802402},{"date":"2026-07-31","current":14.273914,"twenty":-15.021508,"median":16.544918,"eighty":22.406055,"marketCap":132490472588},{"date":"2026-08-07","current":14.117663,"twenty":-14.921083,"median":16.544918,"eighty":22.406055,"marketCap":131040145182},{"date":"2026-08-14","current":14.227699,"twenty":-14.771068,"median":16.544918,"eighty":22.406055,"marketCap":132061502510},{"date":"2026-08-21","current":14.408159,"twenty":-14.72648,"median":16.544918,"eighty":22.406055,"marketCap":133736528528},{"date":"2026-08-28","current":14.733866,"twenty":-14.557005,"median":16.544918,"eighty":22.406055,"marketCap":136759746219},{"date":"2026-09-04","current":14.984749,"twenty":-14.494359,"median":16.544918,"eighty":22.406055,"marketCap":139088440927},{"date":"2026-09-11","current":14.029634,"twenty":-14.410285,"median":16.544918,"eighty":22.406055,"marketCap":130223059320}],"updateTime":1789308162447},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2646350468","title":"Replimune股價下跌，FDA受理皮膚癌藥審評，但諮詢委增添風險","url":"https://stock-news.laohu8.com/highlight/detail?id=2646350468","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646350468?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 21:18","pubTimestamp":1782479903,"startTime":"0","endTime":"0","summary":"BUZZ-Replimune股价下跌，FDA受理皮肤癌药审评，但咨询委增添风险6月26日-** Replimune（REPL.O）股价在盘前交易中下跌4.7%，至10.61美元** Replimune表示，美国食品药品监督管理局（FDA）已受理该公司重新提交的申请(link)，以审查其用于治疗晚期皮肤癌的抗癌药物** Replimune正寻求批准其药物vusolimogene oderparepv","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4T42Y0VX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4585","BK4532","LU0096364046.USD","LU0225284248.USD","LU1670710661.SGD","BK4559","IE0009355771.USD","LU0061475181.USD","LU0456855351.SGD","BK4534","LU1670710588.SGD","LU0882574055.USD","BK4139","LU1074936037.SGD","LU1670711040.USD","BK4581","LU0321505868.SGD","LU1983299246.USD","LU2596442595.SGD","LU1989771016.USD","IE00BFXG1179.USD","LU1883839398.USD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0432979614.USD","LU1323610961.USD","LU1868836757.USD","IE0002141913.USD","LU2360032135.SGD","LU0985481810.HKD","LU2125154778.USD","LU0114720955.EUR","LU0267386448.USD","LU1868836591.USD","LU0306806265.USD","LU1430594728.SGD","LU2133065610.SGD","LU1261432733.SGD","LU1585245621.USD","LU0321505439.SGD","LU1868836914.USD","LU0306807586.USD","BK4588","LU1093756168.USD","BMY","BK4007","LU1670711123.USD","LU1868837300.USD","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645021095","title":"數據簡報-過去十年間美國製藥企業和生物技術公司參與的重大交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021095","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021095?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 19:47","pubTimestamp":1782128872,"startTime":"0","endTime":"0","summary":"数据简报-过去十年间美国制药企业和生物技术公司参与的重大交易新增艾伯维交易路透6月22日 - 艾伯维  已同意以109亿美元现金收购生物技术公司Apogee Therapeutics ，此举旨在帮助这家美国制药商构建其下一代免疫学产品线。此举进一步丰富了过去十年间美国制药公司为收购从肿瘤学、神经学到罕见病及肥胖症等领域有前景疗法而进行的一系列备受瞩目的交易。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nL4S42U0WO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0640478417.SGD","LU2750360997.AUD","03165","LU2023251221.USD","LU2125154778.USD","LU1670711040.USD","BK4533","IE00B3PB1722.GBP","BMY","NUVL","IE0001KFT4U8.USD","LU0784383803.USD","LU2896262040.SGD","PEN","LU0310800965.SGD","GILD","LU0557290698.USD","LU2403377893.USD","LU1066051498.USD","LU0969580561.USD","LU1691799644.USD","BSX","AMGN","LU0708994859.HKD","LU2023250504.SGD","LU2114397693.USD","JNJ","LU0345769128.USD","ABT","IE00BSNM7G36.USD","GSK.UK","LU0949170426.SGD","LU0526926950.USD","MRK","LU0057025933.USD","LU1244550494.USD","AZN.UK","APGE","LU1551013342.USD","LU2361045086.USD","VTRS","LU0128525929.USD","LU0528227936.USD","SG9999015952.SGD","LU0920840948.USD","ABBV","LU0943347566.SGD","LU0058720904.USD","PFE","MTSR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161398792","title":"施貴寶加拿大公司更新指南：治療後推薦在治療中心附近停留時間從28天縮短至14天","url":"https://stock-news.laohu8.com/highlight/detail?id=1161398792","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161398792?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 21:15","pubTimestamp":1781702115,"startTime":"0","endTime":"0","summary":"施贵宝加拿大公司已更新其患者指南，将推荐在接受特定输液治疗后需在治疗中心附近停留的时长，从原先的28天缩短至14天。这一调整反映了对治疗安全性和患者便利性的最新评估，旨在为患者提供更灵活的安排，同时确保必要的医疗监护。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE0002141913.USD","LU2133065610.SGD","LU0432979614.USD","LU1670711123.USD","LU1261432733.SGD","LU0096364046.USD","LU1989771016.USD","LU1032466523.USD","LU1571399168.USD","LU1883839398.USD","BK4581","LU0237698245.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","BK4585","LU1868836914.USD","LU1585245621.USD","LU2125154935.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU2596442595.SGD","LU0868494617.USD","LU0225284248.USD","LU1093756325.SGD","LU1670710588.SGD","LU1868837300.USD","LU2360032135.SGD","LU0882574055.USD","BMY","LU1093756168.USD","BK4588","LU1430594728.SGD","LU0267386448.USD","IE00BFXG1179.USD","BK4532","LU1291159041.SGD","LU1323610961.USD","LU1670711040.USD","LU1983299246.USD","LU1868837136.USD","LU1074936037.SGD","LU0114720955.EUR","LU0061475181.USD","LU1718418525.SGD","LU0985481810.HKD","BK4559","IE00BSNM7G36.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1670710661.SGD","LU2125154778.USD","LU1868836757.USD","LU0225771236.USD","LU0321505868.SGD","LU0456855351.SGD","BK4007","LU0306807586.USD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162302391","title":"施貴寶旗下Breyanzi CAR-T細胞療法在加拿大獲批監測與活動更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1162302391","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162302391?lang=zh_tw&edition=fundamental","pubTime":"2026-06-17 21:11","pubTimestamp":1781701906,"startTime":"0","endTime":"0","summary":"施贵宝加拿大公司宣布，其Breyanzi CAR-T细胞疗法的监测与活动更新方案已获得加拿大监管机构的批准。\n这一批准意味着，该疗法在加拿大的临床应用将遵循更新的监测规程与活动指南。CAR-T细胞疗法作为肿瘤免疫治疗领域的前沿技术，其治疗后的监测与管理对于评估疗效与安全性至关重要。\n监管机构的认可，为医疗专业人员提供了更清晰的框架，以优化患者治疗路径并追踪长期结果。此举有望进一步提升该创新疗法在加拿大医疗体系中的规范应用与患者获益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4581","LU1868836914.USD","LU1670711123.USD","LU1883839398.USD","LU2133065610.SGD","LU1291159041.SGD","LU1989771016.USD","LU0306807586.USD","LU2125154778.USD","LU1670710588.SGD","LU1670711040.USD","LU1571399168.USD","LU1093756325.SGD","IE0002141913.USD","LU0985481810.HKD","LU0225284248.USD","BK4532","LU0321505868.SGD","LU1868836757.USD","BK4585","LU1074936037.SGD","LU0225771236.USD","IE00BSNM7G36.USD","LU0432979614.USD","LU0868494617.USD","LU0306806265.USD","LU1983299246.USD","LU0882574055.USD","LU1032466523.USD","IE0009355771.USD","LU0237698245.USD","LU0456855351.SGD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU2125154935.USD","LU0096364046.USD","LU2242646821.SGD","IE00B2B36J28.USD","LU0321505439.SGD","LU0267386448.USD","LU1868837300.USD","LU2596442595.SGD","BK4534","LU2242652126.USD","IE00BFTCPJ56.SGD","BK4007","LU1261432733.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","LU1585245621.USD","BK4588","LU0114720955.EUR","LU2360032135.SGD","LU1093756168.USD","IE00BFXG1179.USD","BMY","LU1323610961.USD","LU0061475181.USD","LU1670710661.SGD","LU1868837136.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643224312","title":"中國哈伯生物醫藥在獲賠2000萬美元后將聚焦另一項專利訴訟","url":"https://stock-news.laohu8.com/highlight/detail?id=2643224312","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643224312?lang=zh_tw&edition=fundamental","pubTime":"2026-06-15 12:08","pubTimestamp":1781496530,"startTime":"0","endTime":"0","summary":"路透上海6月15日 - 中国哈伯生物医药公司 2142.HK 周一表示，在与美国制药商安进公司 AMGN.O 的知识产权纠纷中胜诉后，该公司将把精力转向另一桩“财务影响远为重大”的专利侵权案。针对声明中提及的具体是哪项专利，Harbour尚未立即回应置评请求。安进公司一名发言人上周判决后向路透表示，该公司将在“庭后程序中就某些重要法律问题向法院寻求裁决”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nL4T42N09Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1064927863.SGD","LU0171293334.USD","LU0784383803.USD","LU0267386448.USD","LU0203347892.USD","BK4585","02142","LU1051770623.HKD","BK4534","LU0997586515.USD","LU0171276677.USD","LU0957799991.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU0029864427.USD","LU1670710661.SGD","AZN.UK","LU1983299246.USD","AMGN","LU0887340254.USD","LU1323610961.USD","LU0096364046.USD","LU1670711040.USD","LU0237698245.USD","LU1074936037.SGD","LU1119994496.HKD","LU1355424745.HKD","LU0920783379.SGD","LU0889566641.SGD","LU1196032939.SGD","LU1170363599.USD","LU1829250122.USD","LU2091194634.USD","LU2125909593.SGD","LU0920840948.USD","LU1301847155.USD","LU2237443622.USD","LU0526926950.USD","LU1989771016.USD","LU0456855351.SGD","LU0310800965.SGD","LU0077335932.USD","LU1487256676.USD","BMY","LU0306807586.USD","LU1015430645.USD","LU0432979614.USD","BK1574","LU2125154935.USD","03165"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642528623","title":"武田製藥的AI研發銀屑病口服藥在頭對頭試驗中勝過百時美施貴寶的Sotyktu","url":"https://stock-news.laohu8.com/highlight/detail?id=2642528623","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642528623?lang=zh_tw&edition=fundamental","pubTime":"2026-06-11 19:01","pubTimestamp":1781175668,"startTime":"0","endTime":"0","summary":"路透6月11日 - 日本武田制药周四表示，其借助人工智能研发的每日一次的银屑病试验性口服药，在一项晚期头对头研究中表现优于百时美施贵宝 已获批的药物Sotyktu。详情如下：这家日本制药商表示，该药物zasocitinib达到了针对中重度斑块型银屑病成人患者的晚期临床试验的主要目标，在经过16周治疗后，其皮肤清除率优于Sotyktu。武田制药表示，扎索西替尼在16周后使35%的患者皮肤完全清除，这一比例是Sotyktu的2.5倍以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nL4T42J0UF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0321505868.SGD","LU2596442595.SGD","LU1868837300.USD","LU2133065610.SGD","LU2468319806.SGD","LU1023059063.AUD","LU0225284248.USD","LU1057294990.SGD","LU0061475181.USD","BK4581","BK4534","LU0985481810.HKD","LU1670710661.SGD","IE00B4R5TH58.HKD","LU0432979614.USD","BK4588","LU0114720955.EUR","LU1883839398.USD","LU0306807586.USD","LU1093756325.SGD","LU0889565916.HKD","LU1670711040.USD","LU1868836914.USD","SG9999001440.SGD","LU1989771016.USD","LU1430594728.SGD","AMGN","LU1291159041.SGD","LU2112291526.USD","IE0009355771.USD","IE00BSNM7G36.USD","LU1670711123.USD","LU2242652126.USD","LU0289739699.SGD","IE0002141913.USD","LU0882574055.USD","BK4599","LU1585245621.USD","LU2360032135.SGD","LU0321505439.SGD","IE00BFXG1179.USD","LU1670710588.SGD","LU0868494617.USD","LU1868837136.USD","BK4559","BK4532","BMY","LU0456855351.SGD","LU1032466523.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642443116","title":"百時美施貴寶(BMY)股票6月8日收盤下跌3.00%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2642443116","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642443116?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 04:15","pubTimestamp":1780949731,"startTime":"0","endTime":"0","summary":"• 受仿制药竞争冲击核心药物影响，百时美施贵宝 (Bristol Myers Squibb) 股价出现下跌。\n• 研发管线受挫以及盈利指引的下调导致市场情绪趋于谨慎。\n• 研发管线的利好消息及监管审批正在推进中。","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261953684-market-movers-bmy-20260608","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE0002141913.USD","LU2133065610.SGD","LU0432979614.USD","LU1670711123.USD","LU1261432733.SGD","LU0096364046.USD","LU1989771016.USD","LU1032466523.USD","LU1883839398.USD","LU0237698245.USD","BK4581","LU1868836591.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","BK4585","LU2125154935.USD","LU1585245621.USD","IE00B2B36J28.USD","LU0868494617.USD","LU1868837300.USD","LU2360032135.SGD","LU0882574055.USD","BMY","LU1093756168.USD","BK4588","LU0267386448.USD","IE00BFXG1179.USD","BK4532","LU1291159041.SGD","LU1323610961.USD","LU1670711040.USD","LU1983299246.USD","LU1868837136.USD","LU1074936037.SGD","LU0114720955.EUR","LU0061475181.USD","LU1718418525.SGD","LU0985481810.HKD","BK4559","IE00BSNM7G36.USD","IE00BFTCPJ56.SGD","LU1670710661.SGD","LU2125154778.USD","LU1868836757.USD","LU0225771236.USD","LU0321505868.SGD","LU0456855351.SGD","LU0306807586.USD","LU1093756325.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145683800","title":"異動解讀｜施貴寶盤中上漲3.13%，多重利好疊加行業回暖共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1145683800","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145683800?lang=zh_tw&edition=fundamental","pubTime":"2026-06-04 22:35","pubTimestamp":1780583737,"startTime":"0","endTime":"0","summary":"6月4日，施贵宝盘中上涨3.13%，报56.09美元/股，成交额1.59亿美元。此外，杰富瑞将公司目标价从70美元上调至73美元，维持买入评级。当日制药行业整体表现强势，礼来涨4.54%，诺和诺德涨4.43%，默沙东涨3.62%，板块联动亦对股价形成支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640942212","title":"健康快訊：放射性植入物可改善腦癌手術後的治療效果","url":"https://stock-news.laohu8.com/highlight/detail?id=2640942212","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640942212?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 00:56","pubTimestamp":1780419386,"startTime":"0","endTime":"0","summary":"研究人员称，这种注入放射性物质的薄层胶原蛋白GammaTile被植入手术切除肿瘤后留下的空腔中，随即开始杀灭任何残留的肿瘤细胞。放射性逐渐减弱，而该植入片会被人体吸收。在一项晚期临床试验中，230名可手术脑转移瘤患者在手术后分别接受了GammaTile植入或标准放射治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nL4S42A1HT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU2213496289.HKD","LU2756315664.SGD","LU2896262040.SGD","LU0109394709.USD","LU1929549753.HKD","LU1496350502.SGD","LU0266013472.USD","LU0683600562.USD","LU1551013342.USD","LU0640476718.USD","LU0980610538.SGD","LU2347655156.SGD","BK4559","IE0002141913.USD","LU0070302665.USD","LU1989772840.SGD","BK4592","LU2236285917.USD","LU1261432733.SGD","IE00BKVL7J92.USD","LU2602419157.SGD","LU0820561818.USD","LU0234570918.USD","LU1699723380.USD","LU0225771236.USD","LU0648001328.SGD","LU2505996681.GBP","LU2403377893.USD","SG9999014542.SGD","LU1732800096.USD","LU2361044949.HKD","MRNX","JNJ","LU0426417589.USD","LU1551013425.SGD","BK4581","LU0985481810.HKD","SGXZ57979304.SGD","SG9999002232.USD","LU1162221912.USD","IE00BBT3K403.USD","BK4585","IE000F7OJYX1.SGD","LU0889565916.HKD","LU1228905037.USD","SG9999002224.SGD","LU1883839398.USD","LU1914381329.SGD","SG9999014567.USD","LU2433249047.HKD","IE0000B7K699.USD","IE00BGHQF631.EUR","LU2125154778.USD","BK4566","LU0861579265.USD","IE00B42XCP33.USD","LU0053666078.USD","MRNY","LU0965508806.USD","LU1196500208.SGD","LU0061475181.USD","LU0211331839.USD","LU1116320901.HKD","LU0345769128.USD","LU1989772923.USD","LU1221951046.USD","LU1116320737.USD","LU1043141123.HKD","LU0985320562.USD","LU1585245621.USD","LU2023250330.USD","LU1934455194.USD","LU1267930813.SGD","LU1935042991.SGD","LU0265550946.USD","LU0267386448.USD","LU1059921491.USD","LU1066051225.USD","LU2089984988.USD","IE0009355771.USD","LU1868837300.USD","LU1917777945.USD","LU2129689605.HKD","LU0965509010.AUD","LU0994945656.USD","LU0795875169.SGD","LU0795875086.SGD","LU2505996509.AUD","IE00B19Z3B42.SGD","LU1061106388.HKD","LU1629891620.HKD","LU0942090050.USD","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","LU2125909593.SGD","MRK","LU0545562505.USD","LU0098860793.USD","LU1032955483.USD","SG9999001440.SGD","LU2242646821.SGD","LU1989771016.USD","LU2361044865.SGD","LU0477156953.USD","LU1868836914.USD","LU1506573853.SGD","BK4532","04332","BK4551","IE0001KFT4U8.USD","LU1291159041.SGD","LU1934455277.USD","LU0210536198.USD","LU0882574055.USD","LU0432979614.USD","LU1066053197.SGD","LU2023250504.SGD","LU1670710661.SGD","IE00BDGV0183.EUR","LU1221951129.SGD","BK4533","LU0265550359.USD","LU0320765646.SGD","LU1201861249.SGD","LU1280957306.USD","LU0965509283.SGD","LU0203345920.USD","LU1145028129.USD","LU1023059063.AUD","LU2417539215.USD","LU1670711123.USD","LU2430703178.SGD","LU1244550577.SGD","LU2430703251.USD","LU1057294990.SGD","LU0058720904.USD","BK4007","LU1778281490.HKD","LU1941712348.USD","SG9999014575.USD","BK4501","LU1894683264.USD","LU1894683348.USD","BK4516","IE00B3T34201.USD","LU1674673428.USD","LU0208291251.USD","IE00BLSP4239.USD","LU0070217475.USD","LU1074936037.SGD","LU2242652126.USD","IE00BVYPNV92.GBP","LU1043141396.HKD","LU0321505868.SGD","SG9999001176.USD","LU0289739699.SGD","LU2133065610.SGD","BK4534","LU1093756168.USD","LU1868836591.USD","LU1670711040.USD","IE00BN8TJ469.HKD","LU1244550221.USD","LU0964807845.USD","LU1868836757.USD","LU1868837136.USD","LU2471134796.USD","LU2491050154.USD","LU1718418525.SGD","IE00BZ1G4Q59.USD","LU0234572021.USD","LU2112291526.USD","IE00BLSP4452.SGD","SG9999013999.USD","LU0238689110.USD","LU0345769631.USD","BK4599","LU0912757837.SGD","LU1037948541.HKD","LU0321505439.SGD","LU1228905540.USD","LU0320765992.SGD","LU0306806265.USD","LU1732799900.SGD","LU2461242641.AUD","LU0345770993.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU0859254822.USD","LU0466842654.USD","LU2750360641.GBP","BK4568","LU1037948897.HKD","LU0203347892.USD","LU1674673691.USD","LU2106854487.HKD","LU1066051498.USD","LU0130517989.USD","LU0965509101.SGD","LU2125154935.USD","LU2125909247.SGD","LU2592432038.USD","IE00BSNM7G36.USD","LU2129689431.USD","IE00B4R5TH58.HKD","SG9999001176.SGD","BK4550","IE000BZT7R73.USD","LU0426412945.USD","LU2750360997.AUD","LU1121112475.USD","LU2756315318.SGD","LU0456855351.SGD","LU0006306889.USD","AMGN","LU0689626769.HKD","LU0345770308.USD","LU1066051811.HKD","BK4588","LU0889566641.SGD","LU2471134523.USD","LU1244550494.USD","SG9999014559.SGD","LU0820561909.HKD","LU1069347547.HKD","IE0002270589.USD","IE000MB6IJN5.SGD","BK4504","IE00B2B36J28.USD","LU2430703095.HKD","IE000WAW04H5.SGD","SG9999015358.SGD","LU1430594728.SGD","LU2491049909.HKD","LU2468319806.SGD","LU0868494617.USD","IE00BFXG1179.USD","LU2487616109.SGD","LU1941712264.USD","LU2357627491.SGD","LU2360032135.SGD","MRNA","LU0868494708.USD","LU0787776722.HKD","IE00BFTCPJ56.SGD","BMY","IE000SO60NU8.SGD","LU1974910355.USD","LU1323610961.USD","LU0237698245.USD","LU0320765489.SGD","LU1093756325.SGD","LU1934455863.HKD","IE0034235303.USD","SG9999015341.SGD","LU2361045086.USD","LU0130102774.USD","LU0792757196.USD","LU0124676726.USD","LU0225284248.USD","LU0943347566.SGD","BK4139","LU2491050071.SGD","IE00B7SZLL34.SGD","LU2471134952.CNY","IE00BJJMRZ35.SGD","LU0210528500.USD","LU0820562030.AUD","BK4548","LU0114720955.EUR","LU1035773651.USD","LU0689472784.USD","LU1670710588.SGD","LU2023250843.SGD","IE000M9KFDE8.USD","LU0096364046.USD","LU2471134879.HKD","LU0306807586.USD","LU0122379950.USD","LU1923622614.USD","LU2324357040.USD","LU2129689514.USD","LU1032466523.USD","LU0106261372.USD","IE00B19Z3581.USD","IE00B1BXHZ80.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134800758","title":"百時美施貴寶：Iza-Bren在重度經治患者群體中展現可控安全性，未觀察到新的安全信號","url":"https://stock-news.laohu8.com/highlight/detail?id=1134800758","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134800758?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 20:04","pubTimestamp":1780401860,"startTime":"0","endTime":"0","summary":"百时美施贵宝（Bristol-Myers Squibb）公布的数据显示，其药物组合Iza-Bren在重度经治的患者群体中表现出可控的安全性特征。研究期间，未观察到任何新的安全信号。这一结果对于此前已接受过多种治疗方案的患者而言，具有积极的临床意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","IE0002141913.USD","LU2133065610.SGD","LU0432979614.USD","LU1670711123.USD","LU1261432733.SGD","LU0096364046.USD","LU1989771016.USD","LU1032466523.USD","LU1571399168.USD","LU1883839398.USD","BK4581","LU0237698245.USD","LU1868836591.USD","IE00BJT1NW94.SGD","LU0321505439.SGD","BK4585","LU1868836914.USD","LU1585245621.USD","LU2125154935.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2242646821.SGD","LU0868494617.USD","LU0225284248.USD","LU1093756325.SGD","LU1670710588.SGD","LU1868837300.USD","LU2360032135.SGD","LU0882574055.USD","BMY","LU1093756168.USD","BK4588","LU1430594728.SGD","LU0267386448.USD","IE00BFXG1179.USD","BK4532","LU1291159041.SGD","LU1323610961.USD","LU1670711040.USD","LU1983299246.USD","LU1868837136.USD","LU1074936037.SGD","LU0114720955.EUR","LU0061475181.USD","LU1718418525.SGD","LU0985481810.HKD","BK4559","IE00BSNM7G36.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU1670710661.SGD","LU2125154778.USD","LU1868836757.USD","LU0225771236.USD","LU0321505868.SGD","LU0456855351.SGD","BK4007","LU0306807586.USD","LU0306806265.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130883268","title":"施貴寶Izalontamab Brengitecan在TNBC和ESCC中展現顯著的OS與PFS改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1130883268","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130883268?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 20:01","pubTimestamp":1780401706,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，其候选药物Izalontamab Brengitecan在三阴性乳腺癌和食管鳞状细胞癌的临床试验中，取得了总生存期与无进展生存期的显著改善。这一积极数据为相关癌症患者带来了新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","IE0009355771.USD","LU0114720955.EUR","LU1670710588.SGD","LU0267386448.USD","BK4532","LU0237698245.USD","IE00B2B36J28.USD","LU1585245621.USD","LU1670710661.SGD","LU1670711040.USD","LU1868836914.USD","LU1989771016.USD","LU2360032135.SGD","LU1868837136.USD","LU0061475181.USD","LU0321505868.SGD","BK4559","LU0985481810.HKD","LU0882574055.USD","LU1868837300.USD","LU0306806265.USD","LU2133065610.SGD","BMY","LU1883839398.USD","BK4534","LU0225284248.USD","LU0321505439.SGD","LU2242646821.SGD","LU1032466523.USD","LU1983299246.USD","LU0306807586.USD","LU1093756168.USD","LU0456855351.SGD","LU1093756325.SGD","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU1670711123.USD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1571399168.USD","LU1291159041.SGD","IE00BSNM7G36.USD","BK4581","LU1868836757.USD","LU2125154935.USD","IE00BFXG1179.USD","LU1074936037.SGD","LU1323610961.USD","BK4007","LU0432979614.USD","BK4585","LU1261432733.SGD","LU0868494617.USD","LU2242652126.USD","LU1718418525.SGD","LU1868836591.USD","LU0096364046.USD","LU2125154778.USD","IE0002141913.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132733869","title":"異動解讀｜施貴寶盤中下跌3.1%，報55.2美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1132733869","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132733869?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 22:23","pubTimestamp":1780323800,"startTime":"0","endTime":"0","summary":"6月1日，施贵宝盘中下跌3.1%，报55.2美元/股，成交额1.68亿美元。施贵宝所在的制药行业中，整体表现疲软，个股中，礼来跌2.2%，强生跌1.51%，辉瑞跌2.08%，默沙东跌2.84%，诺和诺德跌2.39%。百时美施贵宝公司是一家生物制药公司，专注于创新药物的发现、开发、许可、生产、营销和销售，优先关注肿瘤学、血液学、免疫学、心血管和神经科学等领域的变革性药物。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124846858","title":"FDA優先審評施貴寶Camzyos補充新藥申請，用於治療青少年症狀性梗阻性肥厚型心肌病","url":"https://stock-news.laohu8.com/highlight/detail?id=1124846858","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124846858?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 19:00","pubTimestamp":1780311638,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局已接受施贵宝（Bristol-Myers Squibb）提交的Camzyos（Mavacamten）补充新药申请，并授予其优先审评资格。该申请旨在扩展该药物的适应症，用于治疗青少年患者的症状性梗阻性肥厚型心肌病。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0114720955.EUR","LU1989771016.USD","LU2242646821.SGD","LU1261432733.SGD","LU0225771236.USD","IE00BJT1NW94.SGD","IE00BSNM7G36.USD","LU1868836757.USD","IE00B2B36J28.USD","LU0225284248.USD","LU2360032135.SGD","LU1571399168.USD","BMY","LU0321505868.SGD","LU0432979614.USD","LU0096364046.USD","LU1093756325.SGD","LU1430594728.SGD","LU1983299246.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","BK4559","BK4007","BK4581","IE00BFXG1179.USD","LU0868494617.USD","LU1032466523.USD","LU1585245621.USD","LU2125154778.USD","LU2125154935.USD","BK4532","LU1323610961.USD","LU1868837136.USD","LU1670711123.USD","LU1291159041.SGD","LU1670711040.USD","LU0237698245.USD","LU0985481810.HKD","BK4588","LU1868837300.USD","LU1868836914.USD","LU1074936037.SGD","LU0061475181.USD","LU0882574055.USD","LU1868836591.USD","IE00BJJMRZ35.SGD","LU0306807586.USD","LU2133065610.SGD","IE0002141913.USD","LU2242652126.USD","LU0306806265.USD","LU0456855351.SGD","LU1670710661.SGD","LU1718418525.SGD","LU1670710588.SGD","LU1883839398.USD","LU0321505439.SGD","IE0009355771.USD","LU0267386448.USD","BK4534","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120138167","title":"施貴寶免疫療法組合獲批用於治療既往未治療的III/IV期經典霍奇金淋巴瘤成人與青少年患者（12歲及以上）","url":"https://stock-news.laohu8.com/highlight/detail?id=1120138167","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120138167?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 18:59","pubTimestamp":1780311545,"startTime":"0","endTime":"0","summary":"施贵宝公司宣布，其免疫疗法组合方案已获得监管批准，适用于治疗既往未接受过治疗的III期或IV期经典霍奇金淋巴瘤（CHL）患者，覆盖年龄在12岁及以上的成人和青少年人群。这一批准标志着该疗法应用范围的进一步扩大，为更广泛的患者群体提供了新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","LU2125154778.USD","LU0321505868.SGD","LU0306806265.USD","LU0868494617.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU2125154935.USD","BK4585","LU0061475181.USD","IE0002141913.USD","IE0009355771.USD","IE00BFXG1179.USD","LU0306807586.USD","LU1868837300.USD","LU1670710588.SGD","BK4532","LU0267386448.USD","LU1291159041.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU1571399168.USD","LU1868836591.USD","LU0114720955.EUR","LU1868836914.USD","IE00BSNM7G36.USD","LU0237698245.USD","LU1585245621.USD","LU1670711040.USD","LU1868837136.USD","BK4007","LU0456855351.SGD","LU1323610961.USD","LU1983299246.USD","LU1868836757.USD","LU2360032135.SGD","BK4559","LU0882574055.USD","LU1430594728.SGD","LU1032466523.USD","BMY","LU1093756168.USD","LU1883839398.USD","LU2242646821.SGD","LU1093756325.SGD","IE00B2B36J28.USD","LU2133065610.SGD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU0225771236.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","LU1261432733.SGD","LU1670711123.USD","LU1718418525.SGD","LU0321505439.SGD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168315798","title":"施貴寶宣佈歐狄沃®聯合AVD療法獲歐盟擴大標籤，獲批用於一線治療晚期經典型霍奇金淋巴瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1168315798","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168315798?lang=zh_tw&edition=fundamental","pubTime":"2026-06-01 18:55","pubTimestamp":1780311348,"startTime":"0","endTime":"0","summary":"施贵宝宣布，其欧狄沃®（纳武利尤单抗）联合AVD化疗方案，已获得欧盟监管机构批准扩大标签，可用于一线治疗晚期经典型霍奇金淋巴瘤。这一决定标志着该免疫联合疗法在欧洲的应用范围得到进一步拓展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0321505439.SGD","LU0096364046.USD","LU1585245621.USD","LU1868837300.USD","BMY","BK4007","IE00BFXG1179.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1670711123.USD","LU2242646821.SGD","LU1718418525.SGD","LU1323610961.USD","LU1868836591.USD","LU0306807586.USD","IE00BSNM7G36.USD","LU1074936037.SGD","LU1868837136.USD","LU1670710661.SGD","LU0432979614.USD","BK4581","LU0456855351.SGD","LU1670711040.USD","LU1883839398.USD","LU2360032135.SGD","LU1571399168.USD","BK4585","LU2125154935.USD","LU0225771236.USD","LU0267386448.USD","LU1430594728.SGD","BK4534","LU0306806265.USD","LU0882574055.USD","BK4559","LU1989771016.USD","LU0225284248.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1093756325.SGD","LU0868494617.USD","BK4532","LU1670710588.SGD","LU1868836757.USD","LU1868836914.USD","LU1983299246.USD","IE0009355771.USD","LU1032466523.USD","BK4588","LU0985481810.HKD","LU1093756168.USD","LU1261432733.SGD","LU0061475181.USD","LU2125154778.USD","LU0321505868.SGD","LU1291159041.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639760958","title":"Incyte的血液癌症聯合用藥方案可降低疾病進展風險，但副作用發生率較高","url":"https://stock-news.laohu8.com/highlight/detail?id=2639760958","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639760958?lang=zh_tw&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142435,"startTime":"0","endTime":"0","summary":"Incyte的血液癌症联合用药方案可降低疾病进展风险，但副作用发生率较高Monjuvi联合疗法在DLBCL临床试验中降低了疾病进展风险Monjuvi联合疗法严重不良事件和停药率较高，但总体死亡率较低Incyte计划申请扩大美国批准范围，用于一线治疗Christy Santhosh. 路透5月30日 - Incyte公司的 INCY.O Monjuvi 作为多药方案的一部分，该方案包含针对侵袭性非霍奇金淋巴瘤的标准化疗方案，与仅使用标准化疗相比，可将疾病进展、复发或死亡的风险降低25%，但因副作用导致的研究退出率较高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260530:nL4S427034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1032466523.USD","LU1868837136.USD","LU0321505868.SGD","LU0114720955.EUR","LU1261432733.SGD","LU1718418525.SGD","LU2133065610.SGD","LU1585245621.USD","LU2125154935.USD","LU0225284248.USD","BK4534","LU1670710588.SGD","LU0061475181.USD","LU0267386448.USD","LU0096364046.USD","LU0237698245.USD","LU1571399168.USD","LU1868836914.USD","LU0868494617.USD","BK4588","BMY","LU1323610961.USD","LU1868836591.USD","LU0321505439.SGD","LU1093756325.SGD","LU1093756168.USD","LU1983299246.USD","LU1868836757.USD","BK4139","LU1670710661.SGD","IE00B2B36J28.USD","IE0009355771.USD","LU0306807586.USD","LU1291159041.SGD","INCY","LU0225771236.USD","IE00BSNM7G36.USD","BK4585","LU1074936037.SGD","LU1868837300.USD","BK4581","LU2242652126.USD","LU2242646821.SGD","LU2360032135.SGD","LU0456855351.SGD","IE00BFXG1179.USD","BK4559","LU0882574055.USD","BK4007","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639622049","title":"Replimune的皮膚癌藥物在美國獲批迎來第三次機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2639622049","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639622049?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 20:12","pubTimestamp":1780056779,"startTime":"0","endTime":"0","summary":"更新版 4-Replimune的皮肤癌药物在美国获批迎来第三次机会重启申请的消息传出后，股价暴涨86%《华尔街日报》称白宫敦促卫生官员重新审查FDA的驳回决定 Replimune称FDA将优先审查重新提交的申请分析师指出，FDA立场转变的动因尚不明确重写第1段，在第4-5段中补充《华尔街日报》报道的细节，第6段尝试获取评论，最后为股价及要点。路透5月30日 - Replimune公司周五表示，在与美国监管机构达成协议后，计划于未来数日第三次申请其实验性皮肤癌药物的批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4S42613K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670711123.USD","SRPU","MRNX","MRNY","LU1670710661.SGD","LU1718418525.SGD","BK4532","LU1868836591.USD","BK4501","LU1093756325.SGD","BMY","IE00BFXG1179.USD","LU1868837300.USD","LU2242652126.USD","LU1074936037.SGD","BK4007","IE00BJJMRZ35.SGD","SRPT","LU0237698245.USD","LU0868494617.USD","IE0009355771.USD","LU1430594728.SGD","LU1983299246.USD","MRNA","LU0061475181.USD","LU2125154935.USD","LU2242646821.SGD","LU1261432733.SGD","IE0002141913.USD","BK4559","LU0114720955.EUR","LU1868836914.USD","LU1291159041.SGD","BK4551","BK4534","LU0096364046.USD","LU0306806265.USD","LU1883839398.USD","LU1032466523.USD","LU0225771236.USD","REPL","LU0321505868.SGD","BK4568","LU1868836757.USD","BK4548","IE00BFTCPJ56.SGD","LU1571399168.USD","LU1670711040.USD","LU0432979614.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639221346","title":"百時美施貴寶的藥物可延緩難治性多發性骨髓瘤患者的病情進展","url":"https://stock-news.laohu8.com/highlight/detail?id=2639221346","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639221346?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056051,"startTime":"0","endTime":"0","summary":"百时美施贵宝的药物可延缓难治性多发性骨髓瘤患者的病情进展Michael Erman路透5月29日 - 百时美施贵宝公司周五表示，在针对复发或对其他治疗无反应的多发性骨髓瘤患者的晚期临床试验中，其实验性口服药物梅齐多米德延缓了疾病进展。接受百时美施贵宝药物治疗的患者中位无进展生存期为18个月，而对照组仅为8.3个月。接受百时美施贵宝药物治疗的患者中，完全缓解率约为27%，是标准治疗组的三倍，完全缓解通常意味着无法检测到癌症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4S42612M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1061106388.HKD","LU2133065610.SGD","LU2468319806.SGD","LU0096364046.USD","LU1571399168.USD","BK4533","LU1261432733.SGD","LU1718418525.SGD","SG9999001440.SGD","LU1093756168.USD","LU1291159041.SGD","LU1074936037.SGD","LU0306807586.USD","LU2242646821.SGD","BK4559","LU0058720904.USD","LU1868836914.USD","LU1868837136.USD","LU0320765992.SGD","LU1093756325.SGD","LU1868836591.USD","IE00BFTCPJ56.SGD","BK4566","IE0002141913.USD","LU0267386448.USD","LU0122379950.USD","LU0225284248.USD","LU1670710588.SGD","LU2242652126.USD","LU0109394709.USD","BK4581","LU0237698245.USD","LU0321505439.SGD","AMGN","LU0432979614.USD","LU0889565916.HKD","LU2125154778.USD","LU1323610961.USD","LU2125154935.USD","LU0289739699.SGD","BK4139","BK4599","BMY","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU1023059063.AUD","IE00BSNM7G36.USD","LU1983299246.USD","LU1868837300.USD","LU1032466523.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143833745","title":"施貴寶：Mezikd顯著提升二/三線及高危疾病患者無進展生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1143833745","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143833745?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司公布的数据显示，其药物Mezikd在改善患者无进展生存期方面取得了显著成效。这一积极结果覆盖了两个关键的患者群体：接受过二线或三线治疗的患者，以及那些患有更高风险疾病的患者。\n研究结果表明，Mezikd疗法为这些通常预后更具挑战性的患者带来了新的希望。无进展生存期是衡量癌症治疗效果的关键指标，其显著改善意味着疾病进展被有效延缓。这对于临床治疗决策和患者长期管理具有重要指导意义。\n该数据的公布进一步巩固了Mezikd在相关治疗领域的潜力，也为施贵宝公司的产品管线增添了有力证据。后续进展值得市场与医学界持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","LU0321505439.SGD","LU0096364046.USD","LU1585245621.USD","LU1868837300.USD","BMY","BK4007","IE00BFXG1179.USD","LU2133065610.SGD","IE00B2B36J28.USD","LU1670711123.USD","LU2242646821.SGD","LU1718418525.SGD","LU1323610961.USD","LU1868836591.USD","LU0306807586.USD","IE00BSNM7G36.USD","LU1074936037.SGD","LU1868837136.USD","LU1670710661.SGD","LU0432979614.USD","BK4581","LU0456855351.SGD","LU1670711040.USD","LU1883839398.USD","LU2360032135.SGD","LU1571399168.USD","BK4585","LU2125154935.USD","LU0225771236.USD","LU0267386448.USD","LU1430594728.SGD","BK4534","LU0306806265.USD","LU0882574055.USD","BK4559","LU1989771016.USD","LU0225284248.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1093756325.SGD","LU0868494617.USD","BK4532","LU1670710588.SGD","LU1868836757.USD","LU1868836914.USD","LU1983299246.USD","IE0009355771.USD","LU1032466523.USD","BK4588","LU0985481810.HKD","LU1093756168.USD","LU1261432733.SGD","LU0061475181.USD","LU2125154778.USD","LU0321505868.SGD","LU1291159041.SGD","LU0114720955.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160502097","title":"施貴寶：Mezikd安全性特徵與已知的Mezigdomide及聯合療法特徵一致","url":"https://stock-news.laohu8.com/highlight/detail?id=1160502097","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160502097?lang=zh_tw&edition=fundamental","pubTime":"2026-05-29 20:00","pubTimestamp":1780056024,"startTime":"0","endTime":"0","summary":"施贵宝公司公布的数据显示，其研究中的药物Mezikd的安全性特征，与已知的Mezigdomide及联合治疗方案的特征保持一致。这一发现为相关疗法的进一步开发提供了支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","LU2125154778.USD","LU0321505868.SGD","LU0306806265.USD","LU0868494617.USD","LU1989771016.USD","IE00BJT1NW94.SGD","LU0432979614.USD","LU2125154935.USD","BK4585","LU0061475181.USD","IE0002141913.USD","IE0009355771.USD","IE00BFXG1179.USD","LU0306807586.USD","LU1868837300.USD","LU1670710588.SGD","BK4532","LU0267386448.USD","LU1291159041.SGD","LU2242652126.USD","IE00BJJMRZ35.SGD","LU1670710661.SGD","LU1571399168.USD","LU1868836591.USD","LU0114720955.EUR","LU1868836914.USD","IE00BSNM7G36.USD","LU0237698245.USD","LU1585245621.USD","LU1670711040.USD","LU1868837136.USD","BK4007","LU0456855351.SGD","LU1323610961.USD","LU1983299246.USD","LU1868836757.USD","LU2360032135.SGD","BK4559","LU0882574055.USD","LU1430594728.SGD","LU1032466523.USD","BMY","LU1093756168.USD","LU1883839398.USD","LU2242646821.SGD","LU1093756325.SGD","IE00B2B36J28.USD","LU2133065610.SGD","LU1074936037.SGD","IE00BFTCPJ56.SGD","LU0225771236.USD","BK4581","LU0225284248.USD","LU0985481810.HKD","LU1261432733.SGD","LU1670711123.USD","LU1718418525.SGD","LU0321505439.SGD","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}